ISRCTN80046034
Completed
未知
Improving cognitive behavioural therapy for panic by identifying the active ingredients and understanding the mechanisms of action: a multicentre study
German Federal Ministry of Education and Research (Bundesministerium Für Bildung und Forschung [BMBF]) (Germany)0 sites450 target enrollmentFebruary 21, 2007
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- German Federal Ministry of Education and Research (Bundesministerium Für Bildung und Forschung [BMBF]) (Germany)
- Enrollment
- 450
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
2009 Protocol article in http://www.ncbi.nlm.nih.gov/pubmed/19876674 protocol 2011 Results article in http://www.ncbi.nlm.nih.gov/pubmed/21534651 results 2012 Results article in http://www.ncbi.nlm.nih.gov/pubmed/22399019 additional results regarding the impact of depression on CBT 2013 Results article in http://www.ncbi.nlm.nih.gov/pubmed/22921454 results 2020 Results article in https://pubmed.ncbi.nlm.nih.gov/32361414/ results (added 09/03/2021) 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/33846417/ (added 14/04/2021) 2020 Results article in https://pubmed.ncbi.nlm.nih.gov/32987282/ (added 22/10/2021)
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Outpatients
- •2\. 18 to 65 years old
- •3\. Meet current Diagnostic and Statistical Manual of Mental Disorders \- Fourth Edition (DSM\-IV) criteria of panic disorder with/without agoraphobia
- •4\. Hamilton Anxiety Scale (HAMA) score more than or equal to 18 and a Clinical Global Impressions scale (CGI) score more than or equal to four
- •5\. Able to attend clinic on his/her own or accompanied by significant others
- •6\. Informed consent to participate and follow study procedures
Exclusion Criteria
- •1\. DSM\-IV Axis I diagnoses of any psychotic disorder, bipolar disorder, current alcohol or drug dependence and Axis II of borderline personality disorder
- •2\. DSM\-IV Axis I disorders (other than panic disorder and agoraphobia) currently treated either by medications or non\-pharmacological intervention
- •3\. Acute suicidality (Composite International Diagnostic Interview \[CIDI] scale 2\+)
- •4\. General medical contraindications
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Cognitive Behavior Psychotherapy in Panic DisorderPanic DisorderAgoraphobiaNCT01025908Universidade Federal do Rio de Janeiro50
Completed
Not Applicable
Cognitive Behavioural Therapy for psychosis (CBTp) in acute mental health inpatient settingsAcute mental health inpatient service users experiencing psychosisMental and Behavioural DisordersPsychosis, schizophrenia, schizophreniform disorder, schizoaffective disorder, delusional disorder, or psychotic disorder not otherwise specifiedISRCTN59055607niversity College London60
Completed
Not Applicable
Working together against COPDAnxiety and/or depression in people with chronic obstructive pulmonary disease (COPD)Mental and Behavioural DisordersChronic obstructive pulmonary disease (COPD), Anxiety disorder, unspecified, Depressive episode, unspecifiedISRCTN59537391Queen Mary University of London428
Completed
Not Applicable
Does a pain management programme impact on patients quality of sleep?ISRCTN74913595Pfizer Healthcare Ireland (PHI) (Ireland)50
Completed
Not Applicable
Cognitive behavioural therapy software for the treatment of depression in people with multiple sclerosisDepression in people with multiple sclerosis (MS)Mental and Behavioural DisordersDepressive episodes in MS sufferersISRCTN81846800niversity of Sheffield (UK)24